The bitter melon component α-MMC reduced expression of hypoxia-inducible factor 1-alpha (HIF1α) and vascular endothelial growth factor (VEGF) in hypoxic nasopharyngeal carcinoma cells, and inhibited growth of human umbilical vein endothelial cells [77]. This evidence concerns the gene HIF1A and nasopharyngeal carcinoma.